Enterprise record

BIOMERICA INC

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteri

Alpha ID: alpha:company:6865faae-293e-4862-a67e-2d3330c6a706Version: public-1As of: unavailable

10 published Claims2 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 5 claims
    • Legal Name: BIOMERICA INC · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026
    • Published Fact: Healthcare · Claim reviewed: Sep 28, 2026
    • Published Fact: Medical - Devices · Claim reviewed: Sep 28, 2026
  2. BIOMERICA INC DEF 14A 2025-10-20

    sec proxy · Source published: Oct 20, 2025 · Retrieved: Apr 28, 2026

    Supports 5 claims
    • Leadership Role: Allen Barbieri: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: David Moatazedi: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Eric Bing Chin: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Gary Huff: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Zackary Irani: Director · Claim reviewed: Sep 28, 2026